Search

Your search keyword '"Bindoli S"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Bindoli S" Remove constraint Author: "Bindoli S"
65 results on '"Bindoli S"'

Search Results

1. Progress in Biological Therapies for Adult-Onset Still’s Disease

8. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS/MDS ITALIAN EXPERIENCE

9. P013 - Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS/MDS ITALIAN EXPERIENCE

10. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

13. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

14. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

19. Sarcoidosis and Autoimmunity: From Genetic Background to Environmental Factors

22. Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease.

23. Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease.

24. EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.

26. Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis.

28. The role of 18 FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature.

29. Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers.

30. Fertility issues in women of childbearing age with spondyloarthritis.

31. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.

32. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.

33. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.

34. Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome.

35. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.

36. Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease.

37. Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.

38. Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors.

39. IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome.

40. JAK inhibitors for the treatment of VEXAS syndrome.

41. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.

42. New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.

43. A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases.

44. Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review.

45. Regulation of crystal induced inflammation: current understandings and clinical implications.

46. Belimumab: a step forward in the treatment of systemic lupus erythematosus.

47. Autoinflammatory Features in Gouty Arthritis.

48. The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities.

49. 18 F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease.

50. Autoinflammatory Mechanisms in Crystal-Induced Arthritis.

Catalog

Books, media, physical & digital resources